Prilosec 1 Use For GERD Endorsed In 16-2 Joint Committee Vote
This article was originally published in The Tan Sheet
Executive Summary
Possible long-term use of omeprazole to prevent chronic heartburn or gastroesophageal reflux disease (GERD) is acceptable, despite an OTC indication for only 14-day use, FDA advisory committee members determined at a meeting in Bethesda, Md. June 21
You may also be interested in...
Some OTC Switch Benefits Are Intangible, But Influential – CDER’s Ganley
Non-measurable benefits can tip the scales in the benefit-risk consideration of an OTC switch NDA, suggests Charles Ganley, director of CDER's Office of Drug Evaluation. One way to look at non-measurable benefits is OTC ingredients "lower the threshold” for patient “misery” prior to seeking relief, he says.
Some OTC Switch Benefits Are Intangible, But Influential – CDER’s Ganley
Non-measurable benefits can tip the scales in the benefit-risk consideration of an OTC switch NDA, suggests Charles Ganley, director of CDER's Office of Drug Evaluation. One way to look at non-measurable benefits is OTC ingredients "lower the threshold” for patient “misery” prior to seeking relief, he says.
Pricing Strategy Can Help Brands Regain Share Lost To Private Label – Expert
Branded products manufacturers have an array of pricing strategies available to help them regain market share lost to private label during the economic recession, a market researcher says.